Adipose-Derived Stem Cells Help Reduce Lung Scarring in Patients with Pulmonary Fibrosis
Author Information
Author(s): Ouji-Sageshima Noriko, Hiyama Aiko, Kumamoto Makiko, Kitabatake Masahiro, Hara Atsushi, Furukawa Ryutaro, Hontsu Shigeto, Kawaguchi Takeshi, Sawabata Noriyoshi, Muro Shigeo, Ito Toshihiro, De Francesco Francesco, Shridhar Arthi, D’Angelo William
Primary Institution: Nara Medical University
Hypothesis
Can adipose-derived mesenchymal stem cells (ADSCs) reduce fibrosis in lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients?
Conclusion
ADSCs have shown promise in reducing fibrosis-related gene expression in lung fibroblasts from IPF patients and improving lung fibrosis in mouse models.
Supporting Evidence
- ADSC treatment significantly inhibited the expression of fibrosis-related genes in lung fibroblasts.
- ADSCs improved lung fibrosis in both bleomycin-induced and humanized mouse models.
- PTPRR expression was upregulated in lung fibroblasts treated with ADSCs, leading to reduced ERK phosphorylation.
Takeaway
Scientists found that special cells from fat can help heal damaged lungs in people with a serious lung disease called pulmonary fibrosis.
Methodology
The study involved coculturing lung fibroblasts from IPF patients with ADSCs and assessing gene expression and fibrosis in both in vitro and in vivo models.
Potential Biases
Potential bias in patient selection and the influence of external factors on ADSC efficacy.
Limitations
The study primarily used mouse models, which may not fully replicate human disease conditions.
Participant Demographics
Lung samples were obtained from IPF patients undergoing surgical excision.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website